Condition
Pericarditis clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Pericarditis clinical trials that are recruiting, at sites in 12 countries (most in Canada (5), France (4), Italy (3)). 1 was first registered in the last 30 days. By phase: Phase 3 (1), Phase 2 (1), Phase 2/3 (1). The most active sponsors are Ottawa Heart Institute Research Corporation (2), Kiniksa Pharmaceuticals International, plc (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1New in 30 days
- 12Countries
Newest Pericarditis clinical trials
All recruiting trials (9)
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Camptodactyly–Arthropathy–Coxa Vara–Pericarditis (CACP) syndrome patient registry and genetic review
This registry collects clinical and genetic information to better understand CACP syndrome in children with confirmed PRG4 mutations.
-
Transitioning people with recurrent pericarditis to KPL-387 monotherapy dosing and administration
This trial will try switching people with well-controlled recurrent pericarditis from their current therapies to KPL-387 alone for up to 16 weeks to see if symptoms and inflammation stay controlled and the drug is tolerable.
-
Pericardial inflammation imaging to predict recurrent pericarditis
Doctors are testing imaging tools to see if FDG PET/CT and MRI can predict which patients with recurrent pericarditis will flare again.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
KPL-387 for recurrent pericarditis
This trial tests whether KPL-387 can control pain and inflammation and lower the chance of future attacks in people having an acute episode of recurrent pericarditis despite standard treatment.
-
National surveillance of myocarditis and pericarditis after mRNA COVID-19 vaccination
This study is trying to see how mRNA COVID-19 vaccines might affect heart health by following patients who develop heart inflammation after getting vaccinated.
-
Registry for heart inflammation after COVID-19 vaccination
This study is trying to collect information about heart inflammation cases, like myocarditis and pericarditis, that might happen after COVID-19 vaccination to better understand how it affects patients.
-
Identifying Risk Factors for Heart Toxicity from Immune Checkpoint Inhibitors
This study is trying to find out what factors might increase the risk of heart problems in people receiving immune checkpoint inhibitors for cancer treatment.
Related topics
Quick answers
How many Pericarditis clinical trials are recruiting right now?
9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Canada (5 trials), France (4 trials), Italy (3 trials), Spain (3 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.